European Vascular Biology Organisation

The new cardiobiology 2026
2026-02-16 - 2026-02-19 | EMBL Heidelberg and Virtual, EMBL Advanced Training Centre, Heidelberg, Germany
Cardiovascular disease is the leading cause of human mortality, and despite an active research community many of the underlying mechanisms are unknown. Open questions surround molecular triggers, the relationship of GxE, impact of epigenetics, the role of sex, inflammation and microbiome, as well as metabolism and multi-organ links in cardiovascular disease. Advanced molecular and human-mimicking tissue engineering techniques are revolutionizing the way we approach cardiovascular discovery research. These developments led to the inaugural “The new cardiobiology” meeting at EMBL in 2024.In light of further technical advances in the field, the conference will repeat in 2026 and seek to unite speakers across cardiac and vascular biology, tissue engineering as well as systems biology to continue studying cardiovascular disease.
Session topics

Cardiovascular regeneration
Novel 3D multicellular systems
Cardiometabolic complications
Multi-organ disease
New translational breakthroughs

Organisers:

Johannes Backs
Heidelberg University, Germany
Roger Foo
National University of Singapore, Singapore
Kristina Haase
EMBL Barcelona, Spain
Sara S. Nunes de Vasconcelos
University of Toronto, Canada

Deadlines
Abstract submission: 15 Oct 2025
Registration (On-site): 5 Jan 2026
On-site registration
Registration (Virtual): 9 Feb 2026
Virtual Registration
Contact: Catherine Casas-Saavedra

Virtual EVBO Workshop - Practical Immunology for Vascular Biologists : Markers, Methods, and Models
2026-04-21 15:00 - 2026-04-24 17:00 UTC | ZOOM meeting
Prof. Claudia Monaco and the lab
Kennedy Institute of Rheumatology, University of Oxford
Date: Tuesday, 21 April
Time: 15:00–17:00 CET
Format: Online (Zoom link upon registration)
Duration: 2 hours
For EVBO members only. Participation is free, but registration is required.
About the Workshop
The workshop will introduce vascular biologists to vascular immune cell populations and the practical tools we use to study them. Participants will learn:

Immune cells typically found in murine aorta and human arteries
How to profile immune cells using Mass Cytometry (CyTOF)
How to visualize spatial cellular interactions via Imaging Mass Cytometry
When and how to apply complementary tools such as scRNA‑seq and spatial transcriptomics
Practical marker selection, experimental design, and troubleshooting tips

The workshop includes presentations from the Monaco Lab, followed by an interactive Q&A session.
No prior immunology background is required.
Programme
15:00–15:30
Claudia Monaco
Introductory lecture : Immune Cells in Vascular Tissues
Immune populations in murine aorta & human arteries, at baseline and in disease

15:30-16:00
Dave Ahern/Jennifer Cole
Mass Cytometry (CyTOF)
Tissue preparation, panel design, analysis strategies, and pitfalls.
16:00-16:20
Dave Ahern/Jennifer Cole
Imaging Mass Cytometry
Spatial immune–vascular mapping, workflow, and examples.
16:20-16:40
Mohammadali Yavari Ramsheh / Aleksandra Boikova
Complementary Approaches: scRNA‑seq & More
Method selection, data analysis and applications.
16h40-17:00
Q&A Session

EMBO Workshop: Building Networks
2026-05-13 - 2026-05-15 | EMBL Barcelona, Barcelona, Spain
Conference overview
Vascularisation is a rapidly growing field, with researchers across disciplines recognising its crucial role in organ development, disease progression, and therapeutic delivery. Traditionally, vascular biologists have relied on animal models to investigate key processes such as vascular signalling, angiogenesis, and remodelling. These models remain foundational, however, they do not always fully capture human-specific vascular behaviour.
In recent years, advances in multicellular systems, gene editing, stem cell technologies, and bioengineering have created new opportunities to study vascular biology in vitro using human cells.
This upcoming edition of the meeting aims to unite researchers working at the intersection of engineering and vascular biology, facilitating discussions on how to apply cutting-edge techniques in spatial omics, advanced imaging, and the use of AI in vascular research.
Session topics

Vascular development, disease, and models
Mechano-vascular biology
Metabolism, signalling, and angiogenesis
Organ-specific models and biology
Imaging and bioengineered models
Vascular identity, blood and lymphatics
Computational models and AI

Virtual EVBO Workshop - FUNDING YOUR LAB Research Grant Opportunities for Early Career PIs
2026-06-29 16:00 - 2026-07-02 18:00 | ZOOM meeting
Practical guidance on major international funding schemes from experienced investigators and grant experts.
Chair: Serena Zacchigna
Date: Monday, 29 June
Time: 16:00 CET
Format: Online (Zoom link upon registration)
Duration: 2 hours
For EVBO members only. Participation is free, but registration is required.
More information and registration here

About the Workshop
This workshop will provide an overview of key national and international funding opportunities available to early career Principal Investigators. Learn from experienced speakers about different grant schemes, eligibility, application strategies, and tips for building strong proposals.The workshop includes presentations from the Monaco Lab, followed by an interactive Q&A session.
Programme
ERC GRANTS
Starting, Consolidator & Synergy Grants
Mariona Graupera and Karina Yaniv (25 minutes)
HFSP
Elisabeth Jones (10 minutes)
ERAnet
Elisabeth Jones and Mariona Graupera (10 minutes)
MSCA DOCTORAL NETWORKS
Mariona Graupera (10 minutes)
LEDUCQ NETWORKS OF EXCELLENCE
Mikka Vikkula (10 minutes)
INTERACTIVE Q&A
Ask questions directly to experienced
grant holders and evaluators (15+ minutes)

SEEON ANGIOSCIENCE - YOUNG INVESTIGATOR MEETING 2026
2026-09-18 - 2026-09-19 | KLOSTER SEEON, GERMANY, Germany
STEVE SPURGIN AND TULI PRAMANIK, DALLAS
FILIPA OLIVEIRA, HELSINKI
KLOSTER SEEON, GERMANY
ONLINE APPLICATION / ABSTRACT SUBMISSION: FEB 1 – JUN 15, 2026
WWW.VWFB.DE

SEEON ANGIOSCIENCE 2026
2026-09-19 - 2026-09-22 | KLOSTER SEEON, GERMANY, Germany
September 19 -22, 2026
CHAIR: ONDINE CLEAVER, DALLAS
CO-CHAIR: TAIJA MÄKINEN, HELSINKI
INVITED SPEAKERS:
RALF ADAMS – Münster
HELLMUT AUGUSTIN – Mannheim/Heidelberg
RUI BENEDITO – Münster/Madrid
LENA CLAESSON-WELSH – Uppsala
ANNE EICHMANN – New Haven
MAIKE FRYE – Hamburg
HOLGER GERHARDT – Berlin
SHANE HERBERT – Manchester
TIMOTHY HLA – Boston
BEN HOGAN – Melbourne
BONG-IHN KOH – New Haven
TAIJA MÄKINEN – Helsinki
STEFANIA NICOLI – New Haven
TATIANA PETROVA – Lausanne
LI-KUN PHNG – Kobe
MICHAEL POTENTE – Berlin
PIPSA SAHARINEN – Helsinki
MIGUEL TORRES – Madrid
BENOIT VANHOLLEBEKE – Brussels
KLOSTER SEEON, GERMANY
ONLINE APPLICATION / ABSTRACT SUBMISSION: FEB 1 – JUN 15, 2026
WWW.VWFB.DE

Annual Meeting of the The German Society for Microcirculation and Vascular Biology
2026-11-12 - 2026-11-14 | Nationale Akademie der Wissenschaften Leopoldina, Germany
This year, the GfMVB Annual Meeting will take place in the Leopoldina in Halle (Saale), November 12-14, 2026.
We have put together an exciting program covering most up to date aspects of cardiovascular research e.g., responses to damage, vascular dysfunction, repair & remodelling, metabolism and angiogenesis.
During the meeting, there will again be the Emerging Scientist Award session, and the Aletta Jacobs Award session for young female scientists.
More info: https://meetinghand.com/e/httpsgfmvbcompageid199page-content/#about-the-event-6567

2nd European Lymphatic Symposium
2027-04-15 - 2027-04-17
2nd European Lymphatic Symposium
April 15–17, 2027 | Budapest, Hungary
The 2nd European Lymphatic Symposium will take place in Budapest, Hungary, from April 15 to 17, 2027.
This international meeting will bring together global leaders and early‑career scientists in the field of lymphatic vascular biology, with the goal of fostering collaboration, sharing exciting latest research, and providing a platform for young investigators to present their work.
Organizing Committee

Zoltán Jakus, Semmelweis University, Budapest, Hungary
Cornelia Halin, ETH Zurich, Switzerland
Karina Yaniv, Weizmann Institute of Science, Rehovot, Israel and The Helmholtz Institute for Translational AngioCardioScience, Heidelberg, Germany
Taija Mäkinen, Helsinki University, Finland,
Tanya Petrova, University of Lausanne & Ludwig Institute for Cancer Research, Switzerland
